Endotoxemia and cytokine generation in cardiac surgery in relation to flow mode and duration of cardiopulmonary bypass

Shock

Volumn 16, Issue SUPPL., 2001, Pages 39-43

  Neuhof, Christiane ^a   Wendung, Jutta ^b   Dapper, Friedhelm ^b   Bauer, Jürgen ^b   Zickmann, Bernfried ^b   Jochum, Marianne ^b   Tillmanns, Harald ^b   Neuhof, Heinz ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

Cardiopulmonary bypass; Endotoxin; IL 6; IL 8; Pulsatile flow

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BLOOD; CARDIOPULMONARY BYPASS; ENDOTOXEMIA; FEMALE; HEART SURGERY; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; PULSATILE FLOW; TIME;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CYTOKINES; ENDOTOXEMIA; ENDOTOXINS; FEMALE; HUMAN; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGE; PULSATILE FLOW; TIME FACTORS;

EID: 0039435423     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116001-00008     Document Type: Article

References (24)

1. Andersen LW, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen JP: Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93:115-119, 1987.
2. Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG: Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93:832-837, 1987.
3. Khabar KS, el Barbary MA, Khouqeer F, Devol E, al-Gain S, al-Halees Z: Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/ multiple organ dysfunction syndromes. Clin Immunol Immunopathol 85:97-103, 1997.
4. Jansen NJ, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744-747, 1992.
5. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN: Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 20:1090-1096, 1992.
6. Ohri SK, Becket J, Brannan J, Keogh BE, Taylor KM: Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH. Ann Thorac Surg 57:1193-1199, 1994.
7. Andersen LW, Landow L, Baek L, Jansen E, Baker S: Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210-217, 1993.
8. Tao W, Zwischenberger JB, Nguyen TT, Vertrees RA, McDaniel LB, Nutt LK, Herndon DN, Kramer GC: Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 110:819-828, 1995.
9. Subramanian V, McLeod J, Gans H: Effect of extracorporeal circulation on reticuloendothelial function. I. Experimental evidence for impaired reticuloendothelial function following cardiopulmonary bypass in rats. Surgery 64:775-784, 1968.
10. Watarida S, Mori A, Onoe M, Tabata R, Shiraishi S, Sugita T, Nojima T, Nakajima Y, Matsuno S: A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels. J Thorac Cardiovasc Surg 108: 620-625, 1994.
11. Martinez-Pellus AE, Merino P, Bru M, Canovas J, Seller G, Sapina J, Fuentes T, Moro J: Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass: role of type of flow and protective effect of selective digestive decontamination. Intensive Care Med 23:1251-1257, 1997.
12. Neuhof H, Soeparwata R, Neuhof C, Scheld H: Zur pathophysiologischen Rolle von Zytokinen beim kardiopulmonalen Bypass, Infusionsther Transfusionsmed 23(Suppl 4):22-28, 1996.
13. Martinez-Pellus AE, Merino P, Bru M, Conejero R, Seller G, Munoz C, Fuentes T, Gonzalez G, Alvarez B: Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 21:1684-1691, 1993.
14. Quigley RL, Caplan MS, Perkins JA, Arentzon CE, Alexander JC, Kuehn BE, Hoff WJ, Wallock ME: Cardiopulmonary bypass with adequate flow and perfusion pressures prevents endotoxaemia and pathologic cytokine production. Perfusion 10:27-31, 1995.
15. Gercekoglu H, Tarim O, Agar I, Korukcu A, Karabulut H, Soydemir H, Sokullu O, Toklu H, Johansson CB, Yigiter B, Kopman E: Effects of hypothermia on blood endogenous endotoxin levels during cardiopulmonary bypass. J Cardiac Surg 12:223-227, 1997.
16. Bowles CT, Ohri SK, Klangsuk N, Keogh BE, Yacoub MH, Taylor KM: Endotoxaemia detected during cardiopulmonary bypass with a modified Limulus amoebocyte lysate assay. Perfusion 10:219-228, 1995.
17. Imai T, Shiga T, Saruki N, Nishikawa K, Fujita T, Morishita Y: Change in plasma endotoxin titres and endotoxin neutralizing activity in the perioperative period. Can J Anaesth 43:812-819, 1996.
18. Welch M, Douglas JT, Smyth JV, Walker MG: Systemic endotoxaemia and fibrinolysis during aortic surgery. Eur J Vase Endovasc Surg 9:228-232, 1995.
19. Lee JJ, Tyml K, Menkis AH, Novick RJ, Mckenzie FN: Evaluation of pulsatile and nonpulsatile flow in capillaries of goat skeletal muscle using intravital microscopy. Microvasc Res 48:316-327, 1994.
20. Baca I, Bieger W, Mittmann U, Saggau W, Schmidt-Gayk H, Storch HH: Comparative studies on pulsatile and continuous flow during extracorporeal circulation: effects on liver function and endocrine pancreas secretion. Chir Forum Exp Klin Forsch 49-53, 1979.
21. Mathie RT: Hepatic blood flow during cardiopulmonary bypass. Crit Care Med 21(Suppl 2):S72-S76, 1993.
22. Misoph M, Babin-Ebell J: Interindividual variations in cytokine levels following cardiopulmonary bypass. Heart Vessels 12:119-127, 1997.
23. van den Berg RH, Faber-Krol MC, Sim RB, Daha MR: The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 161:6924-6930, 1998.
24. Kreutz M, Ackermann U, Hauschildt S, Krause SW, Riedel D, Bessler W, Andreesen R: A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphylococcus aureus in human monocytes. Immunology 92:396-401, 1997.